curve-top

CALQUENCECaresTM

CALQUENCECares was created to provide you with education and support during treatment.

Sign up today to receive:

  • Information about treatment with CALQUENCE
  • Regular emails with helpful information on managing your treatment

Should questions come up about CALQUENCE, call 1-800-236-9933. Remember, your healthcare provider is your first source of care and information—they should always be contacted for medical advice and treatment.

To sign up, fill out the form below or call 1-800-236-9933.

SIGN UP FOR MORE INFORMATION

caregivers_reg

I am a ...

 Previously Untreated Patent
 Caregiver for previously untreated patient
 Previously Treated Patient
 Caregiver for previously treated patient

Have you received a CALQUENCECaresTM Starter Kit?

 Yes
 No, please send
 
 Yes, I would be willing to share my experience as a patient of CALQUENCE with an AstraZeneca representative.

Yes, I would be willing to share my experience as a patient of CALQUENCE with an AstraZeneca representative.

By completing this registration, I confirm that I am 18 years of age or older and a US resident. I understand that I may also receive ongoing information and support related to CLL/SLL, including treatment information.

AstraZeneca respects your personal health information. The information you provide may be used to send you health-related materials and to develop products, services, and programs. AstraZeneca, or third parties working on our behalf, will not sell or rent personal health information. If, in the future, you no longer want to receive health-related materials, call 1-800-236-9933. Please visit www.azprivacynotice.com to review our Privacy Notice.

 
 
 Submit Button

Tips

First and foremost, thank you—for being generous with your support, for taking the time to learn more, and for making a meaningful difference in the life of someone you care for.

A new CLL/SLL diagnosis or new treatment may seem overwhelming at times, but know that you’re not alone. In the US, you’re one of around 50 million people who will act as a caregiver at some point in their life.

Learning to use some of the below tips, tricks, and strategies can help make things easier.

Be their sounding board

With CLL and SLL treatment come many decisions. Through it all, you can be there to listen, discuss, and collaborate with the person you care for.

Keep letting them call the shots

The person you care for has the right to make decisions about their life as long as they’re able, and it’s important to respect that right.

Offer choices whenever you can

The ability to choose—whether between ice cream flavors or treatment options—is important to everyone, especially the person you care for. Whenever possible, offer choices to help keep their world open and full of possibility.

Be there when they need you

Part of being a caregiver is offering support, even when the person you care for doesn’t ask. Although circumstances may change and needs may vary, thinking ahead to offer support and assistance proactively can go a long way.

Care for yourself, too

Caregiving can be exhausting, especially on top of your everyday responsibilities. Stay in touch with yourself and pay attention to when you’re tired, stressed, or just plain exhausted. Exhaustion can lead even the most well-intentioned caregivers to make bad choices, cause unnecessary frustration, and distract from the needs of the person they’re caring for.

curve-top
curve-top

Downloads

This website is only the start. Feel free to save, share, or print any of the resources below.

Additional Resources

There’s even more help for caregivers out there. Explore the links below to find additional information, community, and more.

American Cancer Society

cancer.org

The American Cancer Society offers programs, support, and information. Learn about treatment options, get advice on coping with side effects, and get answers to questions about health insurance, free services, and much more.

CLL Society

CLLSociety.org

The CLL Society is a patient-centric, physician-curated resource for patients with CLL and their caregivers. In addition to providing helpful information, the CLL Society is a community designed to help meet the unmet needs of those with CLL.

Leukemia & Lymphoma Society (LLS)

lls.org

LLS is a source for free, highly specialized blood cancer information, education, and support for patients, survivors, families, and healthcare professionals. LLS has chapters across the US.

Lymphoma Research Foundation (LRF)

lymphoma.org

LRF is the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and providing support and services to people with lymphoma, their families, and caregivers.

NATIONAL COMPREHENSIVE CANCER NETWORK® (NCCN®)

nccn.org/patients/guidelines/cll

NCCN Guidelines for Patients®, translations of the NCCN clinical guidelines, are meant to help patients with cancer talk with their physicians about the best treatment options for their disease.

Support & Resources for Patients

Savings and support programs, helpful information, and other resources for patients taking CALQUENCE

GO

Important Safety Information

Important Safety Information About CALQUENCE® (acalabrutinib) capsules
+

Before taking CALQUENCE, tell your healthcare provider about all of your medical conditions, including if you:

  • have had recent surgery or plan to have surgery. Your healthcare provider may stop CALQUENCE for any planned medical, surgical, or dental procedure.
  • have bleeding problems.
  • have or had heart rhythm problems.
  • have an infection.
  • have or had liver problems, including hepatitis B virus (HBV) infection.
  • are pregnant or plan to become pregnant. CALQUENCE may harm your unborn baby and cause problems during childbirth (dystocia).
    • If you are able to become pregnant, your healthcare provider may do a pregnancy test before you start treatment with CALQUENCE
    • Females who are able to become pregnant should use effective birth control (contraception) during treatment with CALQUENCE and for at least 1 week after the last dose of CALQUENCE
  • are breastfeeding or plan to breastfeed. It is not known if CALQUENCE passes into your breast milk. Do not breastfeed during treatment with CALQUENCE and for at least 2 weeks after your final dose of CALQUENCE.
Important Safety Information About CALQUENCE® (acalabrutinib) capsules
+

Before taking CALQUENCE, tell your healthcare provider about all of your medical conditions, including if you:

  • have had recent surgery or plan to have surgery. Your healthcare provider may stop CALQUENCE for any planned medical, surgical, or dental procedure.
  • have bleeding problems.
  • have or had heart rhythm problems.
  • have an infection.
  • have or had liver problems, including hepatitis B virus (HBV) infection.
  • are pregnant or plan to become pregnant. CALQUENCE may harm your unborn baby and cause problems during childbirth (dystocia).
    • If you are able to become pregnant, your healthcare provider may do a pregnancy test before you start treatment with CALQUENCE
    • Females who are able to become pregnant should use effective birth control (contraception) during treatment with CALQUENCE and for at least 1 week after the last dose of CALQUENCE
  • are breastfeeding or plan to breastfeed. It is not known if CALQUENCE passes into your breast milk. Do not breastfeed during treatment with CALQUENCE and for at least 2 weeks after your final dose of CALQUENCE.

Tell your healthcare provider about all the medicines you take, including prescription and over-the­-counter medicines, vitamins, and herbal supplements. Taking CALQUENCE with certain other medications may affect how CALQUENCE works and can cause side effects. Especially tell your healthcare provider if you take a blood thinner medicine.

How should I take CALQUENCE?

  • Take CALQUENCE exactly as your healthcare provider tells you to take it.
  • Do not change your dose or stop taking CALQUENCE unless your healthcare provider tells you to.
  • Your healthcare provider may tell you to decrease your dose, temporarily stop, or completely stop taking CALQUENCE if you develop certain side effects.
  • Take CALQUENCE 2 times a day (about 12 hours apart).
  • Take CALQUENCE with or without food.
  • Swallow CALQUENCE capsules whole with a glass of water. Do not open, break, or chew capsules.
  • If you need to take an antacid medicine, take it either 2 hours before or 2 hours after you take CALQUENCE.
  • If you need to take certain other medicines called acid reducers (H2-receptor blockers), take CALQUENCE 2 hours before the acid reducer medicine.
  • If you miss a dose of CALQUENCE, take it as soon as you remember. If it is more than 3 hours past your usual dosing time, skip the missed dose and take your next dose of CALQUENCE at your regularly scheduled time. Do not take an extra dose to make up for a missed dose.

What are the possible side effects of CALQUENCE?

CALQUENCE may cause serious side effects, including:

  • Serious infections can happen during treatment with CALQUENCE and may lead to death. Your healthcare provider may prescribe certain medicines if you have an increased risk of getting infections. Tell your healthcare provider right away if you have any signs or symptoms of an infection, including fever, chills, or flu-like symptoms.
  • Bleeding problems (hemorrhage) can happen during treatment with CALQUENCE and can be serious and may lead to death. Your risk of bleeding may increase if you are also taking a blood thinner medicine. Tell your healthcare provider if you have any signs or symptoms of bleeding, including blood in your stools or black stools (looks like tar), pink or brown urine, unexpected bleeding or bleeding that is severe or you cannot control, vomit blood or vomit that looks like coffee grounds, cough up blood or blood clots, dizziness, weakness, confusion, changes in your speech, headache that lasts a long time, or bruising or red or purple skin marks
  • Decrease in blood cell counts. Decreased blood counts (white blood cells, platelets, and red blood cells) are common with CALQUENCE, but can also be severe. Your healthcare provider should do blood tests to check your blood counts regularly during treatment with CALQUENCE.
  • Second primary cancers. New cancers have happened in people during treatment with CALQUENCE, including cancers of the skin or other organs. Your healthcare provider will check you for skin cancers during treatment with CALQUENCE. Use sun protection when you are outside in sunlight.
  • Heart rhythm problems (atrial fibrillation and atrial flutter) have happened in people treated with CALQUENCE. Tell your healthcare provider if you have any of the following signs or symptoms: fast or irregular heartbeat, dizziness, feeling faint, chest discomfort, or shortness of breath

The most common side effects of CALQUENCE include headache, diarrhea, muscle and joint pain, upper respiratory tract infection, and bruising.

These are not all the possible side effects of CALQUENCE. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

You may report side effects related to AstraZeneca products by clicking here.

What is CALQUENCE?

CALQUENCE is a prescription medicine used to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

It is not known if CALQUENCE is safe and effective in children.

Please see full Prescribing Information, including Patient Information.